Back To Search Instructions
Protocols
18 protocols meet the specified criteria
Disease Site: Other
Protocol No.TitleStatus
01-0331-10Neuroblastoma Biology StudiesOpen
05-0226-04Arizona Lymphoid Tissue and Blood Repository (ALTBR)Open
05-0343-01CLINICOPATHOLOGIC, IMMUNOHISTOCHEMICAL AND KARYOMETRIC FEATURES OF AGGRESSIVE CUTANEOUS SQUAMOUS CELL CARCINOMASOpen
06-0101-03Sentinel Lymph Node Working Group Data Acquisition ProjectOpen
06-0665-10COG AREN0321: Treatment of High Risk Renal Tumors: A Groupwide Phase II StudyOpen
06-0878-10COG AREN0532: Treatment for Very Low, Low, and Standard Risk Favorable Histology Wilms Tumor: A Groupwide Phase III StudyOpen
07-0414-10COG AREN0533: Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms TumorOpen
08-1063-04Pilot Study to Examine the Effect of Over-the-Counter Supplements on Blood Nutrient LevelsOpen
09-0679-04A Phase II Study Of Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT) For Treatment Of Hematologic Malignancies And Hematopoietic Failure StatesOpen
11-0212-04Skin Cancer Institute Patient Registry and Tissue BankOpen
12-0148-04A multicenter safety study of unlicensed investigational cryopreserved cord blood units (CBUs) manufactured by the National Cord Blood Program (NCBP) and provided for unrelated hematopoietic stem cell transplantation of pediatric and adult patientsOpen
12-0229-04Skin Cancer Prevention Program BiorepositoryOpen
12-0652-04A Phase II/III Randomized, Multi-center Trial Comparing Sirolimus plus Prednisone and Sirolimus/Calcineurin Inhibitor plus Prednisone for the Treatment of Chronic Graft-versus-Host-Disease. BMT CTN 0801Open
20110545A Randomized Controlled Study of YONDELIS(Trabectedin) or Dacarbazine for the Treatment of Advanced Liposarcoma or LeiomyosarcomaOpen
20110931Phase 1b, Escalating Dose Study of AVL-292, a Bruton’s Tyrosine Kinase (Btk) Inhibitor, as Monotherapy in Subjects with Relapsed and/or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom’s MacroglobulinemiaOpen
20121336A Phase II/III, multicenter, partially randomized, open label trial investigating safety and efficacy of on-demand and prophylactic treatment with BAY 94-9027 in Severe Hemophilia A Open
COGAGCT0521Treatment of Recurrent or Resistant Pediatric Malignant Germ Cell Tumors with Paclitaxel, Ifosfamide and Carboplatin (COG AGCT0521)Open
NMDP2011-0264A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications, version 3.0 Open